RxDoctor Payments Data

Eugene Shkolyar, MD

Urology · Stanford, CANPI 1851786230

Payments from drug & device makers

$9,887in general payments, 2019–2025

Across 24 payments — averaging $411.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$9K
  • Intuitive Surgical$539
  • Immunitybio, Inc.$117
  • Janssen Scientific Affairs, LLC$98
  • Boston Scientific$44
  • Lumenis, Inc$37
  • plus $106 from 5 others

What the payments were for

  • Consulting fees$7,99581%
  • Travel & lodging$1,24913%
  • Food & beverage$6226%
  • Education$220%

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(3 entities)10$8,946
Intuitive Surgical5$539
Immunitybio, Inc.1$117
Janssen Scientific Affairs, LLC1$98
Boston Scientific1$44
Lumenis, Inc1$37
Bayer1$25
Urogen Pharma, Inc.1$22
Ferring Pharmaceuticals Inc.1$21
ABC Home Medical Supply, Inc.1$20
Ambu Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,887 in reported general payments places this provider in the 75th percentile of 1,324 urology providers in California.

See all urology providers in California

Medicare billing

Part B allowed, 2024
$183,009
Medicare patients
310
Services billed
703

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl17$139

Paid to pharmacies, not to this prescriber.

Other urology in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →